Molecular Characteristics and the Effect of KRAS Mutation on the Prognosis of Immunotherapy in Non-Small Cell Lung Cancer in Xinjiang, China

PURPOSE: Non-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. The Kirsten rat sarcoma vial oncogene (KRAS) gene can affect patient prognosis. In this study, we aim to explore the impact of KRAS mutation status on the clinical prognosis of NSCLC immunotherapy. PATIENTS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Guomin, Yu, Bo, Wan, Hua, Lu, Suqiong, Zhu, Xiaodan, Zhao, Yan, Fuxi, Yujing, Liu, Chunling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512032/
https://www.ncbi.nlm.nih.gov/pubmed/36172169
http://dx.doi.org/10.2147/OTT.S381825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512032/
https://www.ncbi.nlm.nih.gov/pubmed/36172169
http://dx.doi.org/10.2147/OTT.S381825

Ejemplares similares